RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 68 filers reported holding RUBIUS THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $184,000 | -49.2% | 425,497 | 0.0% | 0.00% | -100.0% |
| Q2 2022 | $362,000 | -85.4% | 425,497 | -5.8% | 0.00% | -80.0% |
| Q1 2022 | $2,487,000 | +2140.5% | 451,505 | +3765.3% | 0.01% | +400.0% |
| Q4 2019 | $111,000 | -96.1% | 11,681 | -92.7% | 0.00% | -92.9% |
| Q1 2019 | $2,878,000 | – | 159,046 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,618,351 | $20,554,000 | 22.50% |
| Flagship Pioneering Inc. | 38,296,526 | $300,628,000 | 16.44% |
| HARBOURVEST PARTNERS LLC | 986,878 | $7,747,000 | 3.22% |
| Artal Group S.A. | 2,833,791 | $22,246,000 | 0.89% |
| EcoR1 Capital, LLC | 260,152 | $2,042,000 | 0.26% |
| Cormorant Asset Management, LP | 491,700 | $3,860,000 | 0.24% |
| Nikko Asset Management Americas, Inc. | 1,456,842 | $11,436,000 | 0.20% |
| ARK Investment Management | 730,890 | $5,737,000 | 0.12% |
| Leap Investments LP | 16,300 | $128,000 | 0.06% |
| Baillie Gifford | 4,240,767 | $33,290,000 | 0.04% |